Zura Bio EBIT

As of the most recent data (June 2026), ZURA shows a EBIT of $-92M. That compares with $-72M in the prior-year period — down 27.5% year over year. That is below the sector sector average of $-6.4M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZURA's EBIT is now $-92M (was $-72M) — a 27.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zura Bio is outperforming or lagging.

The its sector sector average EBIT is about $-6.4M. Zura Bio is at $-92M, which is lower that average. That is roughly 1341.5% below the sector mean. Use the comparison chart on this page to see how ZURA stacks up against individual peers as well.

Tracking ZURA's ebit over time shows whether Zura Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $-92M That compares with $-72M in the prior-year period — down 27.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Zura Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-92M) with ownership activity and broader fundamentals.